Grenco Science and Vapium enter into joint venture to introduce Accudose cannabis consumption platformAugust 13, 2019
Vapium Incorporated, a purpose-led, R&D and intellectual property-driven technology company has entered into a joint venture with Grenco Science, a leader in advanced technology cannabis vaporization. The companies will work together to integrate ground-breaking technologies for the medical cannabis industry under the brand name Accudose. The first-of-its-kind cannabis consumption platform will fill a void in the market for an accurate, dosing protocol that will allow practitioners to prescribe cannabis as medicine.
Wildeboer Dellelce LLP acted for Vapium in connection with the joint venture with a team that consisted of Jeff Hergott (corporate/cannabis law) and Katy Pitch (tax).